News > Covid: Pfizer seeks faster approval, tells India its vaccine ‘highly effective’ on dominant variant

Covid: Pfizer seeks faster approval, tells India its vaccine ‘highly effective’ on dominant variant

Scroll | 27/05/2021 11:30 AM | Click to read full article

American pharmaceutical company Pfizer has told the Indian government that its Covid vaccine has shown "high effectiveness" against the virus variant that is dominant in India and on people of Indian ethnicity or nationality

Citing data, the company said the Public Health England in the United Kingdom has reported high vaccine effectiveness of 87.9% against the B.1.617.2 variant, which is most dominant in India.